Also trades as: PHRX.CN (CNQ) · $vol 0M
LMLLF OTC
Pharmadrug Inc.
1W: -20.0%
1M: -32.7%
3M: -26.9%
YTD: -58.4%
1Y: -57.5%
3Y: -94.8%
5Y: -99.4%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+100.0% ▲
Operating Income
-$583K
+56.3% ▲
Net Income
-$793K
+94.0% ▲
EPS (Diluted)
$-0.01
+96.7% ▲
EBITDA
-$583K
+56.3% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $684K | $7K | $0 | $0 | $0 |
| YoY Growth | +12.0% | -99.0% | -100.0% | +0.0% | +0.0% |
| Cost of Revenue | $502K | $9K | $2K | $26K | $0 |
| Gross Profit | $182K | -$2K | -$2K | -$26K | $0 |
| Gross Margin | 26.6% | -30.7% | — | — | — |
| R&D Expenses | $0 | $554K | $713K | $226K | $138K |
| SG&A Expenses | $3M | $2M | $2M | $1M | $445K |
| Operating Expenses | $4M | $3M | $2M | $1M | $583K |
| Operating Income | -$4M | -$3M | -$2M | -$1M | -$583K |
| Operating Margin | -561.5% | -38578.1% | — | — | — |
| Interest Expense | $352K | $60K | $223K | $0 | $0 |
| Income Before Tax | -$6M | -$4M | -$3M | -$14M | -$873K |
| Tax Expense | -$475K | $0 | -$190K | -$1M | $0 |
| Net Income | -$5M | -$6M | -$9M | -$13M | -$793K |
| Net Margin | -753.3% | -83806.5% | — | — | — |
| EPS (Diluted) | $-0.25 | $-0.12 | $-0.06 | $-0.23 | $-0.01 |
| EBITDA | -$4M | -$4M | -$2M | -$1M | -$583K |
| Shares Outstanding | 20M | 47M | 50M | 56M | 104M |